alendronate sodium
Enzyme inhibitors - Alendronic acid was first described in 1978 and approved for medical use in the United States in 1995. It is available as a generic medication. Reference standards of Alendronate Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Alendronate Sodium
Catalogue No.:PA 54 03000
CAS :
129318-43-0
Molecular Formula : C4H12NNaO7P2
Molecular Weight : 271.08

